Form 13-F position report

PROTEOSTASIS THERAPEUTICS I

Reported by Cormorant Asset Management LP

PTI CUSIP 74373B109 Manager CIK 0001583977

Reported 0 shares, down 3,300,000 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2018
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 9 Through Q1 2018

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for PROTEOSTASIS THERAPEUTICS I held by Cormorant Asset Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

69 managers reported PROTEOSTASIS THERAPEUTICS I for Q1 2018.

Managers reporting PROTEOSTASIS THERAPEUTICS I in Q1 2018.
Manager Activity Shares Change % of reported 13F Reported value Tenure
NEA Management Company LLC Unchanged 5,556,778 0 1.17% $26,395,000 9 qtrs
WELLINGTON MANAGEMENT GROUP LLP New 4,827,560 +4,827,560 < 0.01% $22,931,000 1 qtr
JENNISON ASSOCIATES LLC Added 3,621,854 +443,422 0.02% $17,204,000 9 qtrs
RTW INVESTMENTS LP Reduced 1,104,940 -395,060 0.5% $5,248,000 2 qtrs
VANGUARD GROUP INC Added 950,327 +625,756 < 0.01% $4,514,000 8 qtrs
HILLHOUSE INVESTMENT MANAGEMENT LTD Unchanged 865,923 0 0.07% $4,113,000 7 qtrs
FMR LLC Reduced 800,967 -56,533 < 0.01% $3,805,000 9 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 768,804 +609,880 < 0.01% $3,652,000 7 qtrs
Rock Springs Capital Management LP Unchanged 675,000 0 0.14% $3,206,000 9 qtrs
FIL Ltd Unchanged 652,316 0 < 0.01% $3,099,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2018
Filed
May 15, 2018
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.